Hugel B - Search Results

1

[The significance of circulating microparticles in physiology, inflammatory and thrombotic diseases].

Morel O, Morel N, Hugel B, Jesel L, Vinzio S, Goichot B, Bakouboula B, Grunebaum L, Freyssinet JM, Toti F. Morel O, et al. Among authors: hugel b. Rev Med Interne. 2005 Oct;26(10):791-801. doi: 10.1016/j.revmed.2005.03.015. Rev Med Interne. 2005. PMID: 15936118 Review. French.

2

[Procoagulant membranous microparticles and atherothrombotic complications in diabetics].

Morel O, Hugel B, Jesel L, Zobairi F, Bareiss P, Freyssinet JM, Toti F. Morel O, et al. Among authors: hugel b. Arch Mal Coeur Vaiss. 2004 Oct;97(10):1006-12. Arch Mal Coeur Vaiss. 2004. PMID: 16008179 Review. French.

3

Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus.

Morel O, Hugel B, Jesel L, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Freyssinet JM, Toti F. Morel O, et al. Among authors: hugel b. Thromb Haemost. 2004 Feb;91(2):345-53. doi: 10.1160/TH03-05-0294. Thromb Haemost. 2004. PMID: 14961163

4

Cellular microparticles: a disseminated storage pool of bioactive vascular effectors.

Morel O, Toti F, Hugel B, Freyssinet JM. Morel O, et al. Among authors: hugel b. Curr Opin Hematol. 2004 May;11(3):156-64. doi: 10.1097/01.moh.0000131441.10020.87. Curr Opin Hematol. 2004. PMID: 15257014 Review.

5

Membrane microparticles: two sides of the coin.

Hugel B, Martínez MC, Kunzelmann C, Freyssinet JM. Hugel B, et al. Physiology (Bethesda). 2005 Feb;20:22-7. doi: 10.1152/physiol.00029.2004. Physiology (Bethesda). 2005. PMID: 15653836 Free article. Review.

6

Circulating cell-derived microparticles in Crohn's disease.

Chamouard P, Desprez D, Hugel B, Kunzelmann C, Gidon-Jeangirard C, Lessard M, Baumann R, Freyssinet JM, Grunebaum L. Chamouard P, et al. Among authors: hugel b. Dig Dis Sci. 2005 Mar;50(3):574-80. doi: 10.1007/s10620-005-2477-0. Dig Dis Sci. 2005. PMID: 15810645

7

Procoagulant microparticles: disrupting the vascular homeostasis equation?

Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Morel O, et al. Among authors: hugel b. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2594-604. doi: 10.1161/01.ATV.0000246775.14471.26. Epub 2006 Sep 21. Arterioscler Thromb Vasc Biol. 2006. PMID: 16990554 Review.

8

Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury.

Morel N, Morel O, Petit L, Hugel B, Cochard JF, Freyssinet JM, Sztark F, Dabadie P. Morel N, et al. Among authors: hugel b. J Trauma. 2008 Mar;64(3):698-704. doi: 10.1097/TA.0b013e31816493ad. J Trauma. 2008. PMID: 18332810

9

Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles.

Morel O, Jesel L, Hugel B, Douchet MP, Zupan M, Chauvin M, Freyssinet JM, Toti F. Morel O, et al. Among authors: hugel b. J Thromb Haemost. 2003 Jan;1(1):171-7. doi: 10.1046/j.1538-7836.2003.00010.x. J Thromb Haemost. 2003. PMID: 12871555 Free article. Clinical Trial.

10

Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists.

Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Tedgui A, Freyssinet JM, Toti F. Morel O, et al. Among authors: hugel b. J Thromb Haemost. 2004 Jul;2(7):1118-26. doi: 10.1111/j.1538-7836.2004.00805.x. J Thromb Haemost. 2004. PMID: 15219195 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters